| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 09/30/2004 | CA2518734A1 A process for preparing sustained release tablets |
| 09/30/2004 | CA2518709A1 Skin care product containing tall oil fatty acids and vegetable oils for dry and scaling skin and treatment of psoriasis, dermatitis, and eczemas |
| 09/30/2004 | CA2518658A1 Composition and method for appetite and craving suppression and mood enhancement |
| 09/30/2004 | CA2518655A1 Retinoid replacements and opsin agonists and methods for the use thereof |
| 09/30/2004 | CA2518318A1 Histone deacetylase inhibitors |
| 09/30/2004 | CA2518265A1 Novel cyclosporins |
| 09/30/2004 | CA2517588A1 Combination of an aldosterone receptor antagonist and an anti-diabetic agent |
| 09/30/2004 | CA2517283A1 Relaxin3-gpcr135 complexes and their production and use |
| 09/30/2004 | CA2517191A1 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 09/30/2004 | CA2517125A1 Methods for preparation and use of 1.alpha.,24(s)-dihydroxyvitamin d2 |
| 09/30/2004 | CA2517034A1 Fused pyrrole compounds |
| 09/30/2004 | CA2515195A1 Method and system for administering a drug |
| 09/29/2004 | EP1462442A1 Crystals of bicalutamide and process for their production |
| 09/29/2004 | EP1460997A2 Methods for the purification of levofloxacin |
| 09/29/2004 | EP1307436B1 Process for the preparation of baccatin iii derivatives |
| 09/29/2004 | EP1083879B1 Devices for providing prolonged drug therapy |
| 09/29/2004 | EP1071418B1 New treatments for nervous disorders |
| 09/29/2004 | EP1062201B1 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 09/29/2004 | EP1012140B1 New amidino derivatives and their use as thrombin inhibitors |
| 09/29/2004 | EP0878199B1 Natural tea comprising alder and mountain ash extracts for treating the effects of alcoholic drinks |
| 09/29/2004 | EP0699079B1 Bioactive and/or targeted dendrimer conjugates comprising genetic materials |
| 09/29/2004 | CN1533434A Inflenza vaccine composition |
| 09/29/2004 | CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/29/2004 | CN1168717C Novel intermediates for prepn. of antihisatminic piperidine derivatives |
| 09/29/2004 | CN1168448C Medicament for preventing and/or treating a memmary carcinoma, containing a steroidal aromatase inhibitor |
| 09/28/2004 | US6797719 Osteoporosis; antilipemic agents; anticancer agents |
| 09/28/2004 | CA2191088C Copolymer-1 improvements in compositions of copolymers |
| 09/23/2004 | WO2004081007A1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 09/23/2004 | WO2004080459A1 Method for treating mild cognitive impairment and for preventing or delaying alzheimer’s disease |
| 09/23/2004 | WO2004080436A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 09/23/2004 | WO2004080427A2 Method of preventing and treating infections that attack mucosa and assisting rehabilitation thereafter using topically applied ascorbic acid |
| 09/23/2004 | WO2004080425A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080419A2 Humanized antibodies that recognize beta amyloid peptide |
| 09/23/2004 | WO2004080418A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080416A2 Animal model simulating neurologic disease |
| 09/23/2004 | WO2004080413A2 Uses and formulations for transdermal or transmucosal application of active agents |
| 09/23/2004 | WO2004080412A2 Paclitaxel hybrid derivatives |
| 09/23/2004 | WO2004080411A2 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
| 09/23/2004 | WO2004080410A2 Furanose-type bicyclic carbohydrates with biological activity |
| 09/23/2004 | WO2004080408A2 Method of treating cancer with azaspirane compositions |
| 09/23/2004 | WO2004080407A2 New serotonin modulating compounds and uses therefor |
| 09/23/2004 | WO2004080406A2 Therapeutic compositions |
| 09/23/2004 | WO2004080405A2 Igf-binding protein-derived peptide or small molecule |
| 09/23/2004 | WO2004080403A2 Influenza virus vaccine |
| 09/23/2004 | WO2004080402A2 Potassium salt of an hiv integrase inhibitor |
| 09/23/2004 | WO2004080401A2 Oral insulin therapies and protocol |
| 09/23/2004 | WO2004080399A2 Rapidly absorbing lipophilic skin compositions and uses therefor |
| 09/23/2004 | WO2004080396A2 Liposomal curcumin for treatment of cancer |
| 09/23/2004 | WO2004080395A2 Methods and compositions for cancer treatment |
| 09/23/2004 | WO2004080391A2 Novel antibacterial agents |
| 09/23/2004 | WO2004080390A2 Antiprotozoal imidazopyridine compounds |
| 09/23/2004 | WO2004080389A2 Hydroxyeicosadienamide compounds |
| 09/23/2004 | WO2004080387A2 Immunogenic cd19 ligand-antigenic molecule complexes and fusion proteins |
| 09/23/2004 | WO2004080386A2 Optimization of bacterial sucab expression by promoter mutagenesis for efficient l-glutamic acid production |
| 09/23/2004 | WO2004080385A2 Compositions and methods for diagnosing and treating an inflammation |
| 09/23/2004 | WO2004080384A2 Method of treating chronic joint pain |
| 09/23/2004 | WO2004080380A2 Use of catechuic polyphenols for preparing compositions for stimulating a skin's natural pigmentation |
| 09/23/2004 | WO2004080373A2 Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2) |
| 09/23/2004 | WO2004080371A2 Injectable isotonic solution of gatifloxacin pre-diluted in glucose. |
| 09/23/2004 | WO2004071464A8 Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells |
| 09/23/2004 | WO2004069156A3 Inactivated probiotic bacteria and methods of use thereof |
| 09/23/2004 | WO2004066914A3 Variant integrin polypeptides and uses thereof |
| 09/23/2004 | WO2004064721A3 A pyrazolopyrimidine compound and a process for preparing the same |
| 09/23/2004 | WO2004064708A3 Solution for nostril wash |
| 09/23/2004 | WO2004058173A3 Method and apparatus of sterilizing internal passages of a centrifuge centrate gate |
| 09/23/2004 | WO2004047735A3 Broad spectrum anti-viral therapeutics and prophylaxis |
| 09/23/2004 | WO2004047717A3 Topical application of curcumin for the treatment of peripheral neuropathy |
| 09/23/2004 | WO2004041217A3 Synthetic lactone formulations and method of use |
| 09/23/2004 | WO2004041199A3 N-acetyl-d-glucosamine (nag) supplemented food products and beverages |
| 09/23/2004 | WO2004039430A3 Method of treating insulin resistance, adult onset diabetes and metabolic syndrome x |
| 09/23/2004 | WO2004030634A3 Therapeutic compositions |
| 09/23/2004 | WO2004028444A3 Parathyroid hormone antagonists and uses thereof |
| 09/23/2004 | WO2004021989A3 Imidazolopyridines and methods of making and using the same |
| 09/23/2004 | WO2004016231A3 PROTECTION OF PATIENTS LACKING A FUNCTIONAL SPLEEN AGAINST S. PNEUMONIAE WITH PNEUMOCOCCAL SURFACE PROTEIN A (PspA) |
| 09/23/2004 | WO2004010947A3 Humanized antibodies against human 4-1bb |
| 09/23/2004 | WO2003096969A3 Novel lambda phage display system and the process |
| 09/23/2004 | US20040186509 Nosebleed lip pack |
| 09/23/2004 | US20040186283 Synthesis of 5-azacytidine |
| 09/23/2004 | US20040186163 Novel combination |
| 09/23/2004 | US20040186143 Lactams as modulators of chemokine receptor activity |
| 09/23/2004 | US20040186140 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 09/23/2004 | US20040186102 such as {4-Chloro-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethoxy]phenyl}-(2-methylquinolin-4-yl)amine for treatment of cardiovascular disorders, kidney disorders, pain and inflammation |
| 09/23/2004 | US20040186065 Forms of 5-azacytidine |
| 09/23/2004 | US20040186063 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 09/23/2004 | US20040186052 Administering to a patient suffering from neurological disorder a therapeutically effective amount of an RDP-58 peptide |
| 09/23/2004 | US20040186047 Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing |
| 09/23/2004 | US20040185931 Enhanced gaming system |
| 09/23/2004 | US20040185122 Selective COX-2 inhibition from edible plant extracts |
| 09/23/2004 | US20040185098 Making oral dosage form by forming granules comprising oxycodone hydrochloride, alkyl cellulose and polymethacrylate, and drying said granules |
| 09/23/2004 | US20040185097 Controlled release modifying complex and pharmaceutical compositions thereof |
| 09/23/2004 | US20040185096 Melt-extrusion multiparticulates |
| 09/23/2004 | US20040185068 Self-emulsifying compositions, methods of use and preparation |
| 09/23/2004 | US20040185049 Administering to animal an interleukin-27R/cytokine receptor (IL-27R/WSX-1) ligand to treat autoimmune diseases; antiasthmatics, antiallergens, and antiinflammatory agents; diabetes |
| 09/23/2004 | US20040185023 unencapsulated heat-generating agent and at least one encapsulated catalase, and a peroxide component that react when combined together to produce heat |
| 09/23/2004 | US20040184993 allows the modulation of the mass median aerodynamic diameter of the aerosol particles on actuation of the inhaler to a value which is suited for the pulmonary administration |
| 09/23/2004 | US20040182703 Systems and methods for blood glucose sensing |
| 09/23/2004 | CA2801100A1 Novel antibacterial agents |
| 09/23/2004 | CA2518912A1 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | CA2518898A1 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |